MedPath

Cognitive Behavioural Therapy for Sexual Concerns During Perimenopause

Not Applicable
Conditions
Sexual Concerns
Perimenopause
Interventions
Other: Cognitive Behavioural Therapy
Registration Number
NCT04922385
Lead Sponsor
St. Joseph's Healthcare Hamilton
Brief Summary

Given the high rates and associated impairment of sexual concerns during the menopausal transition, and specifically during perimenopause, our team has developed a CBT protocol specifically designed to target these prevalent and distressing sexual concerns. The broad aim of the proposed study is to validate this new protocol in a clinic that provides empirically-supported assessment and intervention services for women with menopause-related symptoms. The primary objective of this study is to evaluate the efficacy of a four-week individual CBT protocol in improving sexual satisfaction and reducing distress during perimenopause. The secondary objective of this study is to evaluate the efficacy of this CBT protocol to improve sexual functioning (e.g., desire, arousal), relationship satisfaction, and body image. Exploratory analyses will examine the impact on this CBT protocol on vasomotor symptoms, depression, and anxiety.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
62
Inclusion Criteria
  1. 40-60 years of age;
  2. peri-menopausal and have had a menstrual period within the previous twelve months as per the STRAW definition (Harlow et al., 2012);
  3. cut-off score of 26 or lower on the Female Sexual Functioning Index, indicating sexual dysfunction (Wiegel et al., 2005);
  4. medication stable (e.g., hormone therapy), with no changes in dosing for the previous three months (Green et al., 2019);
  5. no psychological treatment to address sexual dysfunction and/or sexual concerns within the previous six months; and
  6. speak, read, and write in English to comprehend testing procedures and written materials in treatment
  7. living within Canada
Exclusion Criteria
  1. participants with psychotic disorders, or current substance and/or alcohol dependence; and
  2. participants who are severely depressed/suicidal at time of the intake assessment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
CBTCognitive Behavioural TherapyIndividual 4-week CBT protocol
Primary Outcome Measures
NameTimeMethod
Female Sexual Desire Questionnaire (FSDQ)6 weeks

The FSDQ (Goldhammer \& McCabe, 2011) is a 50-item self-report questionnaire assessing one's experience of and sexual desire for women across six domains: dyadic desire, solitary desire, resistance, positive relationship, sexual self-image, and concern. Total scores range from 50 to 300, with higher scores indicated increased sexual desire.

The Female Sexual Function Index (FSFI)6 weeks

The FSFI (Rosen et al., 2000) is a six domain measure of female sexual functioning including sexual desire, subjective arousal, lubrication, orgasm, satisfaction, and pain. Scores on the FSFI range from 2-36, which higher scores indicating a greater level of sexual function.

Female Sexual Distress Scale-Revised (FSDS-R)6 weeks

The FSDS-R (DeRogatis et al., 2008) is a 13-item self-report questionnaire assessing various aspects of sexual distress, with a clinical cut-off score of 11 indicated sexual distress. Scores on the FSDS-R range from 0 to 48, with higher scores indicating greater sexual distress.

Secondary Outcome Measures
NameTimeMethod
36-Item Short-Form Health Survey (SF-36)6 weeks

The SF-36 (Ware \& Sherbourne, 1992) is a 36-item self-administered questionnaire assessing one's perception of overall health and well-being. Higher scores on each domain indicate a more favourable health state in that area.

The Beck Depression Inventory-II (BDI-II)6 weeks

The BDI-II (Beck et al., 1996) is a self-report questionnaire and one of the most widely used tools for measuring depression. Total scores on the BDI-II range from 0-63, with higher scores indicating increased depressive symptom severity.

The Couples Satisfaction Index (CSI)6 weeks

The CSI (Funk \& Rogge, 2007) is a 32-item scale designed to measure one's satisfaction in a relationship. Total scores on the CSI range from 0-81, with higher scores indicating greater couples satisfaction.

The Hot Flash Related Daily Interference Scale (HFRDIS)6 weeks

The HFRDIS (Carpenter, 2001) assesses the degree to which vasomotor symptoms interfere with daily life. Higher scores on the HFRDIS indicate higher interference due to hot flashes and thus, greater impact on quality of life.

The Greene Climacteric Scale (GCS)6 weeks

The GCS (Greene, 1998) is a self-report questionnaire measuring four menopause-related domains: vasomotor symptoms, depression and anxiety, physical complaints, and sexual concerns. Studies have shown women who score greater than 12 on the GCS are more likely to be menopausal.

The Hamilton Anxiety Scale (HAM-A)6 weeks

The HAM-A (Hamilton, 1959) is a clinician administered questionnaire developed to quantify the severity of anxiety symptomatology and is considered a gold-standard. Total scores on the HAM-A range from 0-56, with greater scores indicating increased anxiety severity.

Cognitive Flexibility Inventory (CFI)6 weeks

The CFI (Dennis \& Vander Wal, 2010) is a 20-item self-report questionnaire that assesses three aspects of cognitive flexibility: tendency to perceive difficult situations as controllable, ability to perceive multiple alternative explanations for life occurrences and human behaviour, and ability to generate multiple alternative solutions to difficult situations. Higher scores are indicative of greater cognitive flexibility when encountering stressful situations.

Dresden Body Image Questionnaire (DBIQ)6 weeks

The DBIQ (Scheffers et al., 2017) is a 35-item self-report questionnaire assessing one's feelings of their physical appearance across five subscales: body acceptance, sexual fulfillment, physical contact, vitality, and self-aggrandizement. Higher score on the DBIQ indicate a more positive body image.

Trial Locations

Locations (1)

St. Joseph's Healthcare Hamilton

🇨🇦

Hamilton, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath